TwinBeech Capital’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-12,777
Closed -$2.64M 699
2025
Q4
$2.64M Buy
+12,777
New +$2.53M 0.19% 146
2025
Q3
Sell
-17,016
Closed -$2.6M 698
2025
Q2
$2.6M Buy
+17,016
New +$2.62M 0.06% 285
2025
Q1
Sell
-108,857
Closed -$15.7M 832
2024
Q4
$15.7M Buy
108,857
+76,428
+236% +$11.8M 0.27% 118
2024
Q3
$5.26M Buy
32,429
+29,445
+987% +$4.69M 0.1% 236
2024
Q2
$436K Sell
2,984
-27,873
-90% -$4.15M 0.01% 460
2024
Q1
$4.88M Buy
30,857
+29,241
+1,809% +$4.65M 0.1% 217
2023
Q4
$253K Sell
1,616
-31,477
-95% -$4.83M ﹤0.01% 593
2023
Q3
$5.15M Buy
+33,093
New +$5.46M 0.1% 258
2022
Q3
Sell
-2,226
Closed -$395K 723
2022
Q2
$395K Sell
2,226
-17,075
-88% -$3.04M 0.02% 435
2022
Q1
$3.42M Sell
19,301
-160
-0.8% -$27.2K 0.15% 181
2021
Q4
$3.33M Buy
19,461
+7,845
+68% +$1.28M 0.19% 156
2021
Q3
$1.88M Buy
11,616
+10,382
+841% +$1.77M 0.13% 228
2021
Q2
$203K Buy
+1,234
New +$204K 0.02% 415
2020
Q3
Sell
-11,243
Closed -$1.58M 505
2020
Q2
$1.58M Buy
+11,243
New +$1.64M 0.35% 91
2020
Q1
Sell
-9,028
Closed -$1.32M 385
2019
Q4
$1.32M Buy
+9,028
New +$1.22M 0.38% 83

Other funds holding JNJ

TwinBeech Capital's JNJ Position: Q1 2026 in Review

TwinBeech Capital sold out of Johnson & Johnson (JNJ) in Q1 2026, closing a stake of 12,777 shares — an estimated $2.64M sold.

TwinBeech Capital first reported a position in JNJ in Q4 2019 and held it in 15 quarters. The position peaked at $15.7M in Q4 2024. 4,641 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • TwinBeech Capital reported no remaining Johnson & Johnson position as of Q1 2026 after selling out during the quarter.
  • TwinBeech Capital sold 12,777 Johnson & Johnson shares in Q1 2026, an estimated $2.64M.
  • TwinBeech Capital first reported a position in Johnson & Johnson in Q4 2019 and held it in 15 quarters.
  • TwinBeech Capital's Johnson & Johnson position peaked at $15.7M in Q4 2024.
  • 4,641 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on TwinBeech Capital's 13F filing for Q1 2026, filed 15 May 2026.